The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey

OBJECTIVE: Turkey is one of the latest countries that COVID-19 disease was reported, with the first case on March 11, 2020,and since then, Istanbul became the epicenter of the pandemic in Turkey. Here, we reveal sequences of the virus isolatedfrom three different patients with various clinical presentations.METHODS: Nasopharyngeal swab specimens of the patients were tested positive for the COVID-19 by qRT-PCR. Viral RNAextraction was performed from the same swab samples. Amplicon based libraries were prepared and sequenced using theIllumina NextSeq platform. Raw sequencing data were processed for variant calling and generating near-complete genomesequences. All three genomes were evaluated and compared with other worldwide isolates.RESULTS: The patients showed various clinics (an asymptomatic patient, patient with mild disease, and with severe pulmonary infiltration). Amplicon-based next-generation sequencing approach successfully applied to generate near-completegenomes with an average depth of 2616. All three viral genomes carried the D614G variant (G clade according to GISAIDclassification) with implications for the origin of a spread first through China to Europe then to Istanbul.CONCLUSION: Here, we report the viral genomes circulating in Istanbul for the first time. Further sequencing of the virusisolates may enable us to understand variations in disease presentation and association with viral factors if there is any. Inaddition, the sequencing of more viral genomes will delineate the spread of disease and will guide and ease the necessarymeasures taken to stem the spread of the novel coronavirus.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 107. Available at: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200506covid-19-sitrep-107. pdf?sfvrsn=159c3dc_2. Accessed May 15, 2020.
2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536–44.
3. Dallavilla T, Bertelli M, Morresi A, Bushati V, Stuppia L, Beccari T, et al. Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses. Eur Rev Med Pharmacol Sci 2020; 24:4558–64.
4. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–3.
5. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 2009;7:439–50.
6. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015;386:995–1007.
7. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69:1002–9.
8. Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, et al. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg 2020 Apr 8 [Epub ahead of print], doi: 10.1001/jamaoto.2020.0832.
9. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Weekly 2020;2:113–22.
10. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020;94:154–5.
11. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25:2000180.
12. Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:458–64.
13. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62.
14. Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 2009;106:5871–6.
15. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020;11:1620.
16. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260–3.
17. Berngruber TW, Froissart R, Choisy M, Gandon S. Evolution of virulence in emerging epidemics. PLoS Pathog 2013;9:e1003209.
18. Zhan SH, Deverman BE, Chan YA. SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?. bioRxiv 2020;1–28.
19. Doganay L, Ozdil K, Memisoglu K, Katrinli S, Karakoc E, Nikerel E, et al. Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB. North Clin Istanb 2017;4:1–3.
20. Andrews S. FastQC: a quality control tool for high throughput sequence data. Available at: https://www.bioinformatics.babraham. ac.uk/projects/fastqc/. Accessed May 15, 2020.
21. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal 2011;17:10–2.
22. Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv 2013;1–3.
23. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078–9.
24. Grubaugh ND, Gangavarapu K, Quick J, Matteson NL, De Jesus JG, Main BJ, et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol 2019;20:8.
25. Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 2018;34:4121–3.
26. Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evolution 2018;4:vex042.
27. T.C. Sağlık Bakanlığı. COVID-19 (SARS-CoV-2 enfeksiyonu) rehberi. Available at: https://covid19bilgi.saglik.gov.tr/depo/rehberler/ COVID-19_Rehberi.pdf?type=file. Accessed May 15, 2020.

APA	KARACAN İ, AKGÜN T, AĞAOĞLU N, İRVEM A, ALKURT G, Yıldız J, KÖSE B, ÖZEL A, ALTUNAL L, CAN N, Kendir Demirkol y, AYDIN M, Akgun-Dogan O, DOĞANAY L, Dinler Doganay G (2020). The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. , 203 - 209. 10.14744/nci.2020.90532
Chicago	KARACAN İlker,AKGÜN Tuğba KIZILBOĞA,AĞAOĞLU N. Buğra,İRVEM Arzu,ALKURT Gizem,Yıldız Jale,KÖSE Betsi,ÖZEL A. Serra,ALTUNAL L. Nilsun,CAN Nisan DENİZCE,Kendir Demirkol yasemin,AYDIN MEHTAP,Akgun-Dogan Ozlem,DOĞANAY Levent,Dinler Doganay Gizem The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. (2020): 203 - 209. 10.14744/nci.2020.90532
MLA	KARACAN İlker,AKGÜN Tuğba KIZILBOĞA,AĞAOĞLU N. Buğra,İRVEM Arzu,ALKURT Gizem,Yıldız Jale,KÖSE Betsi,ÖZEL A. Serra,ALTUNAL L. Nilsun,CAN Nisan DENİZCE,Kendir Demirkol yasemin,AYDIN MEHTAP,Akgun-Dogan Ozlem,DOĞANAY Levent,Dinler Doganay Gizem The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. , 2020, ss.203 - 209. 10.14744/nci.2020.90532
AMA	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. . 2020; 203 - 209. 10.14744/nci.2020.90532
Vancouver	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. . 2020; 203 - 209. 10.14744/nci.2020.90532
IEEE	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G "The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey." , ss.203 - 209, 2020. 10.14744/nci.2020.90532
ISNAD	KARACAN, İlker vd. "The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey". (2020), 203-209. https://doi.org/10.14744/nci.2020.90532

APA	KARACAN İ, AKGÜN T, AĞAOĞLU N, İRVEM A, ALKURT G, Yıldız J, KÖSE B, ÖZEL A, ALTUNAL L, CAN N, Kendir Demirkol y, AYDIN M, Akgun-Dogan O, DOĞANAY L, Dinler Doganay G (2020). The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. İstanbul Kuzey Klinikleri, 7(3), 203 - 209. 10.14744/nci.2020.90532
Chicago	KARACAN İlker,AKGÜN Tuğba KIZILBOĞA,AĞAOĞLU N. Buğra,İRVEM Arzu,ALKURT Gizem,Yıldız Jale,KÖSE Betsi,ÖZEL A. Serra,ALTUNAL L. Nilsun,CAN Nisan DENİZCE,Kendir Demirkol yasemin,AYDIN MEHTAP,Akgun-Dogan Ozlem,DOĞANAY Levent,Dinler Doganay Gizem The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. İstanbul Kuzey Klinikleri 7, no.3 (2020): 203 - 209. 10.14744/nci.2020.90532
MLA	KARACAN İlker,AKGÜN Tuğba KIZILBOĞA,AĞAOĞLU N. Buğra,İRVEM Arzu,ALKURT Gizem,Yıldız Jale,KÖSE Betsi,ÖZEL A. Serra,ALTUNAL L. Nilsun,CAN Nisan DENİZCE,Kendir Demirkol yasemin,AYDIN MEHTAP,Akgun-Dogan Ozlem,DOĞANAY Levent,Dinler Doganay Gizem The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. İstanbul Kuzey Klinikleri, vol.7, no.3, 2020, ss.203 - 209. 10.14744/nci.2020.90532
AMA	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. İstanbul Kuzey Klinikleri. 2020; 7(3): 203 - 209. 10.14744/nci.2020.90532
Vancouver	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. İstanbul Kuzey Klinikleri. 2020; 7(3): 203 - 209. 10.14744/nci.2020.90532
IEEE	KARACAN İ,AKGÜN T,AĞAOĞLU N,İRVEM A,ALKURT G,Yıldız J,KÖSE B,ÖZEL A,ALTUNAL L,CAN N,Kendir Demirkol y,AYDIN M,Akgun-Dogan O,DOĞANAY L,Dinler Doganay G "The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey." İstanbul Kuzey Klinikleri, 7, ss.203 - 209, 2020. 10.14744/nci.2020.90532
ISNAD	KARACAN, İlker vd. "The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey". İstanbul Kuzey Klinikleri 7/3 (2020), 203-209. https://doi.org/10.14744/nci.2020.90532